PRKDC and neoplasm: In summary, the efficacy of these ATM and DNA-PKcs inhibition trials is yet to be reported and it will also be interesting to what extent radiosensitization conferred through these approaches will be tumor specific, since both proteins are also mandatory for effective DNA repair in normal tissue cells and deficiencies result in severe radiosensitivity [42, 43].